Mutation JAK2 V617F in patients with myeloproliferative disorders and technical aspects of its detection.

被引：0
|
作者：
Pekova, Sona
Hoffmann, Rudolf
Jindra, Pavel
Novakova, Ludmila
Kozak, Tomas
Vozobulova, Vera
Schutzova, Miroslava
Balasz, Jozef
Tomsikova, Lucie
Prucha, Miroslav
机构：
[1] Hosp Na Homolce, Dept Clin Biochem Hematol & Oncol, Prague, Czech Republic
[2] Fac Hosp, Dept Hematol Oncol, Plzen, Czech Republic
[3] Fac Hosp Kralovske Vinohrady, Dept Clin Hematol, Prague, Czech Republic
来源：
BLOOD | 2006年 / 108卷 / 11期
关键词：
D O I：
10.1182/blood.V108.11.4906.4906
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4906
引用
收藏
页码：313B / 313B
页数：1
相关论文
共 50 条
  • [1] JAK2 V617F mutation and the myeloproliferative disorders
    Vainchenker, William
    Casadevall, Nicole
    HEMATOLOGIE, 2006, 12 (01): : 3 - 7
  • [2] The JAK2 V617F mutation in the myeloproliferative disorders
    Sale, MA
    Awan, A
    Lucas, GS
    Yin, JAL
    BRITISH JOURNAL OF HAEMATOLOGY, 2006, 133 : 33 - 33
  • [3] The V617F JAK2 mutation and the myeloproliferative disorders
    Percy, MJ
    McMullin, MF
    HEMATOLOGICAL ONCOLOGY, 2005, 23 (3-4) : 91 - 93
  • [4] Rapid detection of JAK2 V617F mutation in myeloproliferative disorders
    Mir, Rashid
    AbuDuhier, Faisal M.
    ANNALS OF ONCOLOGY, 2016, 27
  • [5] JAK2 (V617F) mutation in patients with chronic myeloproliferative disorders
    Hamidah, N.
    Farisah, N.
    Jalil, N.
    Fei-Liang, W.
    AWahid, F.
    Othman, A.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2008, 30 : 121 - 122
  • [6] JAK2 V617F mutation and VEGF levels in patients with myeloproliferative disorders
    Bourantas, L.
    Chatzikyriakidou, A.
    Panteli, K.
    Bai, M.
    Bourantas, D. K.
    Tsiara, St.
    Georgiou, I.
    Bourantas, K. L.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 547 - 548
  • [7] Incidence and significance of the JAK2 V617F mutation in patients with chronic myeloproliferative disorders
    Langabeer, S. E.
    Ainle, F. Ni
    Conneally, E.
    Lawler, M.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2007, 176 (02) : 105 - 109
  • [8] Incidence and significance of the JAK2 V617F mutation in patients with chronic myeloproliferative disorders
    S. E. Langabeer
    F. Ni Ainle
    E. Conneally
    M. Lawler
    Irish Journal of Medical Science, 2007, 176 : 105 - 109
  • [9] A study of JAK2 (V617F) gene mutation in patients with chronic myeloproliferative disorders
    Hamidah, N. H.
    Farisah, N. R.
    Azlinda, A. B.
    Wong, F. L.
    Das, S.
    Fadillah, S. A. W.
    Ainoon, O.
    CLINICA TERAPEUTICA, 2012, 163 (02): : 109 - 113
  • [10] Prevalence of JAK2 V617F mutation in Indian patients with chronic myeloproliferative disorders
    Sazawal, Sudha
    Bajaj, Jyoti
    Chikkara, Sunita
    Jain, Sonal
    Bhargava, Rahul
    Mahapatra, Manoranjan
    Saxena, Renu
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2010, 132 (04) : 423 - 427
12345